[Ortho] Профилактика тромбозов у детей

[Данила Курышев]

Bonduel M. M. Oral anticoagulation therapy in children//Thromb. Res. 
2006: 118: 85–94.
Crowther M. A., Ginsberg J. S., Julian J. et al. A comparison of two 
intensities of warfarin for the prevention of recurrent thrombosis in 
patients with the antiphospholipid antibody syndrome//New. Engl. J. Med. 
2003; 349: 1133–1138.
Finkelstein Y., Nurmohamed L., Avner M. et al. Clopidogrel use in 
children//J. Pediatr. 2005; 147: 657–661.
Harrison L., Johnston M., Massicotte M. P. et al. Comparison of 5-mg and 
10-mg loading doses in initiation of warfarin therapy//Ann. Intern. Med. 
1997; 126: 133–136.
Jilma B., Kamath S., Lip G. Y. H. Antithrombotic therapy in special 
circumstances. II—  In children thrombophilia, and miscellaneous 
conditions//BMJ. 2003; 326: 37–40.
John C. M., Harkensee C. Thrombolytic agents for arterial and venous 
thromboses in neonates//The Cochrane Database of Systematic Reviews. 
2005; 25: CD004342.
Kandiah D. A., Krilis S. A. Immunology of antiphospholipid antibodies 
and their interaction with plasma proteins//Lupus. 1996; 5: 153–155.
Kearon C. Duration of anticoagulation for venous thromboembolism//J. 
Thrombosis. Thrombolysis. 2001; 12: 59–65.
Keller T. T., Squizzato A., Weeda V. B., Middeldorp S. Clopidogrel and 
aspirin versus aspirin for preventing cardiovascular disease in those at 
high risk//The Cochrane Database of Systematic Reviews 2005; 1: CD005158.
Kutteh W. H. Antiphospholipid antibodies and reproduction//J. Reprod. 
Immunol. 1997; 35: 151–171.
Lee A. C. W., Li C. H., Szeto S. C., Ma E. S. K. Symptomatic venous 
thromboembolism in Hong Kong Chinese Children//Hong Kong Med. J. 2003; 
9: 259–262.
Merkel N., Gunther G., Schobess R. Long-term treatment of thrombosis 
with enoxaparin in pediatric and adolescent patients//Acta. Haematol. 
2006; 115: 230–23
Данила Курышев